NeuroPI: Patient Safety: Falls
Each NeuroPI module is prepared by distinguished faculty who are acknowledged leaders in their respective fields. Each module is composed of a set of multiple-choice items with preferred responses, instructions on how to collect cases to assess one's practice, and resources for creating and implementing an improvement program. Participants are able to compare their performance pre- and post-intervention to assess what changes have occurred in their practice.
As a result of this program the learner will:
- Assess performance via chart audit comparing current performance with measures and best practices in order to select improvements to make.
- Consult educational resources related to the measure(s) selected for improvement, design an intervention, and implement an improvement plan.
- Re-evaluate performance via chart audit comparing current practice with measures and best practices to determine whether an improvement has been achieved as a result of the intervention.
- Summarize practice, process and/or outcome changes resulting from the activity.
- Inquiry of falls within the last 12 months
- Inquiry into the circumstances of falls
- Assessment of balance and gait using a standardized scale
- Orthostatic blood pressure measurements for patients with a history of falls
- Review of medications that may contribute to falls
- Visual assessment or referral for assessment
- Inquiry and intervention for home fall hazards
- Assessment of cognitive function
- Consideration of assistive device
- Consideration or referral for balance, gait, and strength training
As a result of this program, the participant will determine individual practice gaps and address them through a performance improvement plan designed to improve competence, performance, and patient outcomes.
- Interpersonal Skills and Communication
- Medical Knowledge
- Patient Care
- Practice-based Learning and Improvement
Date of Release
December 22, 2011
This module is eligible for CME credits for three years from the release date.
Confidentiality of Data
All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved.
The American Academy of Neurology Institute (AANI) is not requesting any individually identifiable health information as defined by HIPAA privacy guidelines. The data you submit to the AANI through NeuroPI is de-identified, as it neither identifies nor provides a reasonable basis to identify an individual. All information submitted to the AANI through NeuroPI is confidential. Data may be used and presented anonymously and in aggregate by the AANI.
Patients must be tracked separately from NeuroPI to ensure confidentiality. Within the NeuroPI modules, your patients will be identified using a 4-digit patient code that you create. Any other identifying information is strictly prohibited. Please use the NeuroPI Patient Tracker to create your 4-digit patient codes for your personal reference. The NeuroPI Patient Tracker should not be shared with AANI.
JOHN G. NUTT, MD, FAAN
Porfessor of Neurology
Oregon Health & Science University
*Dr. Nutt has received personal compensation for activities with XenPort, Impax Laboratories, Neurogen, Synosia, Neuroderm, Merck, Lily/Medtronic, Elan Pharmaceuticals, Lundbeck, Merz Pharmaceuticals, Synagile, and the National Parkinson Foundation. Dr. Nutt has received research support from Merck.
RICHARD CAMICIOLI, MD
Professor of Neurology
University of Alberta, Edmonton
*Dr. Camicioli has nothing to disclose.
FAY HORAK, PhD, PT
Professor of Neurology Adjunct Professor of Physiology and Biomedical Engineering
Oregon Health and Science University
*Dr. Horak is Chief Scientific Officer in the start-up device company APDM. Dr. Horak's research as been supported by government and other nonprofit foundations.
DONALD J. IVERSON, MD, FAAN
Humboldt Neurological Medical Group, Eureka, California
*Dr. Iverson has nothing to disclose.
RALPH F. JOZEFOWICZ, MD, FAAN
AAN Board Member
University of Rochester, Rochester, New York
*Dr. Jozefowicz has received personal compensation in an editorial capacity for The Neurologist.
CYNTHIA L. COMELLA, MD, FAAN
Education Committee Chair
Rush University Medical Center, Chicago, Illinois
*Dr. Comella has received personal compensation for activities with Ipsen, Merz Pharma, Allergan, Inc., UCB Pharma, and Eisai Inc., as a consultant. Dr. Comella's institution has received research support from Merz Pharma, Allergan, Inc., Ipsen, and Boehringer Ingelheim Pharmaceuticals, Inc.
JONATHAN P. HOSEY, MD, FAAN
Practice Committee Chair
Geisinger Medical Center, Danville, Pennsylvania
*Dr. Hosey has nothing to disclose.
Tracy King, MA, Senior Manager, Education
*Ms. King has nothing to disclose.
Amy Wallace, Program Manager, Patient Safety
*Ms. Wallace has nothing to disclose.
Susan Rodmyre, Director, Education
*Ms. Rodmyre has nothing to disclose.
Lori Strachota, Program Manager, Conference Management, Registration
*Ms. Strachota has nothing to disclose.
+ Unlabeled Use of Products/Investigational Use Disclosure